Corneal Crosslinking with Epioxa
Corneal crosslinking is the only treatment shown in clinical trials to slow or stop keratoconus from getting worse. It uses riboflavin (vitamin B2) eye drops and ultraviolet light to form new bonds between the collagen fibers of the cornea, stiffening it so it stops thinning and bulging.
Georgia Eye Partners was the first practice in Georgia to offer Epioxa, the first FDA-approved crosslinking treatment that leaves the cornea’s protective outer layer, the epithelium, in place.
A More Comfortable Crosslinking Experience
Traditional crosslinking required removing the cornea’s protective outer layer, called the epithelium, so the riboflavin drops could soak in. This left a scraped area that took several days to heal and caused most of the pain and blurry vision people associate with crosslinking.
Epioxa takes a different approach. Its riboflavin drops are designed to pass through the outer layer, so it stays in place. During treatment, you’ll wear special goggles that deliver extra oxygen to help the treatment work effectively. With no surface wound to heal, recovery is usually faster and more comfortable. Epioxa is now the crosslinking treatment we use for every patient.
Who is a Candidate for Corneal Crosslinking With Epioxa?
Epioxa is FDA-approved to treat keratoconus in adults and in children 13 and older.
Eye doctors often recommend crosslinking when:
- Your keratoconus is progressing, shown by changes in your corneal scans or prescription over time
- You are a teenager or young adult with newly diagnosed keratoconus and reduced vision, since progression is most likely at younger ages
- You are having CTAK, CAIRS or topography-guided PRK and would benefit from a stronger cornea
Crosslinking may not be right if your cornea is very thin or scarred in the center, if you are pregnant, or if you have had herpes infections of the eye. Its goal is to stabilize the cornea, but it doesn’t substantially restore vision, so if your vision can’t be corrected with glasses or contacts, we’ll consider other options.
What Happens on Treatment Day?
Crosslinking is a quick, in-office procedure done with numbing drops, so you stay comfortable throughout. Here’s what to expect:
- We gently clean the surface of your eye, leaving the protective outer layer in place.
- You’ll receive two strengths of Epioxa riboflavin drops over about 10 minutes.
- We rinse your eye and measure the thickness of your cornea.
- You’ll wear special oxygen goggles and look at a light for about 11 minutes while the UV treatment is applied.
- We place a soft bandage contact lens to protect your eye as it heals.
The treatment itself takes just over 20 minutes, plus a little extra time to get you settled and prepared.
What is Recovery Like After Corneal Crosslinking With Epoxia?
Most people have some irritation, watering and light sensitivity for the first day or two, and sunglasses help. Redness of the white of the eye was the most common side effect in the Epioxa trials. You’ll use eye drops for a short time, and we remove the bandage lens at a follow-up visit.
The goal of crosslinking is stability. Vision may fluctuate for a few weeks, and some corneas flatten slightly over the following months. Improvements in vision usually come from the other treatments in our Refractive Keratoconus Clinic, which work best on a cornea that has stopped changing.
Combining Crosslinking With Other Treatments
Crosslinking is often paired with treatments that reshape the cornea to improve vision, and the order matters.
With CTAK or CAIRS, we place the donor tissue first and perform crosslinking a few weeks later. This allows the cornea to reshape as much as possible before it’s strengthened.
With topography-guided PRK, we do the opposite. We crosslink first, then perform the laser treatment six months to a year later, once the cornea has stabilized.
FAQs About Corneal Crosslinking
Schedule a Crosslinking Evaluation
If you or your child has keratoconus, especially if it was diagnosed recently or your prescription keeps changing, request an appointment online or call (404) 531-9988. Bring any earlier corneal scans you have.
References
- Epioxa (riboflavin 5′-phosphate ophthalmic solution) prescribing information. Glaukos Corporation; 2025. DailyMed
- Hagem AM, et al. Dramatic reduction in corneal transplants for keratoconus 15 years after the introduction of corneal collagen crosslinking. Cornea. 2024;43(4):437-442. doi:10.1097/ICO.0000000000003401